Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain
Name:
1-s2.0-S2211124721014066-main.pdf
Size:
3.346Mb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Pharmacology, Arizona Health Sciences Center, University of ArizonaIssue Date
2021Keywords
chronic painD1 receptor
dopamine
HCN channels
levodopa
monoamines
neuromodulation
ongoing pain relief
pain aversiveness
prefrontal cortex
top-down pain modulation
Metadata
Show full item recordPublisher
Elsevier B.V.Citation
Lançon, K., Qu, C., Navratilova, E., Porreca, F., & Séguéla, P. (2021). Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain. Cell Reports.Journal
Cell ReportsRights
Copyright © 2021 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Pyramidal neurons in the anterior cingulate cortex (ACC), a prefrontal region involved in processing the affective components of pain, display hyperexcitability in chronic neuropathic pain conditions, and their silencing abolishes hyperalgesia. We show that dopamine, through D1 receptor (D1R) signaling, inhibits pyramidal neurons of mouse ACC by modulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Activation of Gs-coupled D1R by dopamine induces the opening of HCN channels at physiological membrane potentials, driving a significant decrease in input resistance and excitability. Systemic L-DOPA in chronic neuropathic mice rescues HCN channel activity, normalizes pyramidal excitability in ACC, and blocks mechanical and thermal allodynia. Moreover, microinjection of a selective D1R agonist in the ACC relieves the aversiveness of ongoing neuropathic pain, while an ACC D1R antagonist blocks gabapentin- and lidocaine-evoked antinociception. We conclude that dopaminergic inhibition via D1R in ACC plays an analgesic role in physiological conditions and is decreased in chronic pain. © 2021 The AuthorsNote
Open access journalISSN
2211-1247Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1016/j.celrep.2021.109933
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

